[go: up one dir, main page]

SV1997000002A - 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas ref. lea 31477-sv - Google Patents

2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas ref. lea 31477-sv

Info

Publication number
SV1997000002A
SV1997000002A SV1997000002A SV1997000002A SV1997000002A SV 1997000002 A SV1997000002 A SV 1997000002A SV 1997000002 A SV1997000002 A SV 1997000002A SV 1997000002 A SV1997000002 A SV 1997000002A SV 1997000002 A SV1997000002 A SV 1997000002A
Authority
SV
El Salvador
Prior art keywords
dihidroquinolinil
tio
oxo
oxazolidinonas
ref
Prior art date
Application number
SV1997000002A
Other languages
English (en)
Inventor
Bernd Riedl
Dieter Habich
Andreas Stolle
Martin Ruppelt
Stephan Bartel
Walter Guarnieri
Rainer Endermann
Hein-Peter Kroll
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV1997000002A publication Critical patent/SV1997000002A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A 2-OXO- Y 2-TIO-1,2-DIHIDROQUINOLINIL-OXAZOLINONAS, PROCEDIMIENTO PARA SU PRODUCCION Y UN USO COMO MEDIACAMENTO, ESPECIALMENTE COMO MEDICAMENTO ANTIBACTERIANO.
SV1997000002A 1996-01-16 1997-01-16 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas ref. lea 31477-sv SV1997000002A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601265A DE19601265A1 (de) 1996-01-16 1996-01-16 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone

Publications (1)

Publication Number Publication Date
SV1997000002A true SV1997000002A (es) 1997-08-29

Family

ID=7782816

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1997000002A SV1997000002A (es) 1996-01-16 1997-01-16 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas ref. lea 31477-sv

Country Status (28)

Country Link
US (1) US5861413A (es)
EP (1) EP0785197A3 (es)
JP (1) JPH09194478A (es)
KR (1) KR970059174A (es)
AR (1) AR005458A1 (es)
AU (1) AU711924B2 (es)
BG (1) BG62257B1 (es)
BR (1) BR9700688A (es)
CA (1) CA2194945A1 (es)
CO (1) CO4520188A1 (es)
CZ (1) CZ12897A3 (es)
DE (1) DE19601265A1 (es)
EE (1) EE9700019A (es)
HN (1) HN1996000124A (es)
HR (1) HRP960614A2 (es)
HU (1) HUP9700126A3 (es)
IL (1) IL119994A0 (es)
NO (1) NO970174L (es)
NZ (1) NZ314057A (es)
PE (1) PE35398A1 (es)
PL (1) PL317930A1 (es)
SG (1) SG46764A1 (es)
SK (1) SK5897A3 (es)
SV (1) SV1997000002A (es)
TN (1) TNSN97009A1 (es)
TR (1) TR199601002A1 (es)
YU (1) YU1097A (es)
ZA (1) ZA97302B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
CN1288462A (zh) 1998-01-23 2001-03-21 法玛西雅厄普约翰美国公司 噁唑烷酮组合库、组合物和制备方法
KR20010052615A (ko) * 1998-06-05 2001-06-25 다비드 에 질레스 옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6544991B2 (en) 2000-06-30 2003-04-08 Pharmacia & Upjohn Company Compositions and methods for treating bacterial infections
JP2004518677A (ja) * 2000-12-21 2004-06-24 ファルマシア・アンド・アップジョン・カンパニー 抗菌性キノロン誘導体および細菌感染を治療するためのその使用
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
WO2003031441A1 (en) * 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
DE60304360T2 (de) * 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
WO2004026848A1 (en) * 2002-09-20 2004-04-01 Lupin Limited Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
AR042086A1 (es) * 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
ATE411312T1 (de) * 2002-12-04 2008-10-15 Glaxo Group Ltd Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
JP2006516989A (ja) * 2003-02-07 2006-07-13 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤として使用するための二環式環によりｎ−置換されたオキサゾリジノン誘導体
BRPI0407252A (pt) * 2003-02-07 2006-01-31 Warner Lambert Co Agentes antibacterianos.
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20070155714A1 (en) 2003-04-30 2007-07-05 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
JP2007516263A (ja) 2003-12-18 2007-06-21 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー オキサゾリジノン−キノロンハイブリッド抗生物質
US7494578B2 (en) * 2004-03-01 2009-02-24 Atotech Deutschland Gmbh Iron-phosphorus electroplating bath and method
AU2005270951A1 (en) * 2004-08-06 2006-02-16 Pharmacia & Upjohn Company Llc Oxazolidinones containing oxindoles as antibacterial agents
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
RU2501799C2 (ru) * 2008-02-22 2013-12-20 Актелион Фармасьютикалз Лтд Поизводные оксазолидинона
EP3177593A1 (en) * 2014-08-06 2017-06-14 Novartis AG Quinolone derivatives as antibacterials
KR20220055171A (ko) * 2020-10-26 2022-05-03 주식회사 아이비스바이오 포말리도마이드로부터 3,6'-디티오포말리도마이드를 선택적으로 합성하는 방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4801600A (en) 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US4942183A (en) * 1987-10-16 1990-07-17 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
EP0609905B1 (en) 1988-09-15 2001-06-06 PHARMACIA & UPJOHN COMPANY 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
JP2669579B2 (ja) * 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (es) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
ZA97302B (en) 1997-07-17
TNSN97009A1 (fr) 2005-03-15
CA2194945A1 (en) 1997-07-17
HUP9700126A3 (en) 1999-05-28
KR970059174A (ko) 1997-08-12
TR199601002A1 (tr) 1997-08-21
NO970174D0 (no) 1997-01-15
SK5897A3 (en) 1997-09-10
HN1996000124A (es) 1997-06-18
BG62257B1 (bg) 1999-06-30
CO4520188A1 (es) 1997-10-15
PE35398A1 (es) 1998-08-29
NO970174L (no) 1997-07-17
US5861413A (en) 1999-01-19
DE19601265A1 (de) 1997-07-17
HRP960614A2 (en) 1998-02-28
AU711924B2 (en) 1999-10-21
HU9700126D0 (en) 1997-02-28
AU1009797A (en) 1997-07-24
EP0785197A2 (de) 1997-07-23
MX9700419A (es) 1997-07-31
IL119994A0 (en) 1997-04-15
YU1097A (sh) 1999-12-27
NZ314057A (en) 1998-11-25
SG46764A1 (en) 1998-02-20
HUP9700126A2 (hu) 1998-12-28
BR9700688A (pt) 1998-09-01
EP0785197A3 (de) 1999-02-10
PL317930A1 (en) 1997-07-21
JPH09194478A (ja) 1997-07-29
AR005458A1 (es) 1999-06-23
BG101131A (en) 1998-04-30
EE9700019A (et) 1997-08-15
CZ12897A3 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
SV1997000002A (es) 2-oxo y 2-tio-1,2-dihidroquinolinil-oxazolidinonas ref. lea 31477-sv
SV1997000003A (es) Tienil- y furanil-oxazolidinonas piridocondensadas ref. lea 31502-sv
SV1995000045A (es) Benzoxazolil- y benzotiazoliloxazolidinonas, ref. le a 30616-sv
SV1997000009A (es) Nuevas oxazolidinonas sustituidas ref. lea 31534-sv
SV1995000041A (es) Heteroarik-oxazolidinonas de 6 eslabones con contenido de nitrogeno le a 30522-sv
SV1995000042A (es) Heteroaril-oxazolidinonas de 5 eslabones ref. le a 30523-sv
DE69017167D1 (de) Organisches polymer, dessen herstellung und härtbare zusammensetzung, die es enthält.
ES2164182T3 (es) Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana.
SV2004001432A (es) 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv
NO970210L (no) Heteroatomholdige cyklopentanopyridyl-oksazolidinoner
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
SV1996000026A (es) Benzociclopentano oxazolidinonas que contienen heteroatomos
MX9700885A (es) Nuevas heteroariloxazolidinonas.
ID23374A (id) Halogenopirimidin
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
ES2172937T3 (es) 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides.
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
SV1997000025A (es) Nuevos pirimido /1,2-a/ indoles ref. lea 31544-sv
BG101401A (bg) Състави за орално приложение с удължено освобождаване на цисаприд
SV1997000010A (es) Nuevas heteroariloxazolidinonas ref. lea 31535-sv
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
SV2002000355A (es) Aril- y heteroarilsulfonatos ref. lea 34321-sv
ECSP972001A (es) 2-oxo y 2 -tio -1,2 - dihidroquinolinil- oxazolidinonas
ES2157419T3 (es) Arilazadioxacicloalquenos substituidos, fungicidas.